ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells (Q46514784)

22 December 2017

title

ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells (English)

1 reference

22 December 2017

1 reference

Yuki Izawa

1

1 reference

22 December 2017

Masanori Yoshizumi

2

1 reference

22 December 2017

Yoshiko Fujita

3

1 reference

22 December 2017

Nermin Ali

4

1 reference

22 December 2017

Yasuhisa Kanematsu

5

1 reference

22 December 2017

Keisuke Ishizawa

6

1 reference

22 December 2017

Koichiro Tsuchiya

7

1 reference

22 December 2017

Toshiyuki Obata

8

1 reference

22 December 2017

Yousuke Ebina

9

1 reference

22 December 2017

Shuhei Tomita

10

1 reference

22 December 2017

Toshiaki Tamaki

11

1 reference

22 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

22 December 2017

Experimental Cell Research

published in

1 reference

22 December 2017

volume

308

1 reference

22 December 2017

issue

2

1 reference

22 December 2017

page(s)

291-299

1 reference

22 December 2017

Close relationship of abnormal glucose tolerance with endothelial dysfunction in hypertension.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

The cross-talk between angiotensin and insulin differentially affects phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-mediated signaling in rat heart: implications for insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Insulin resistance and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Endogenous angiotensin II suppresses insulin signaling in vascular smooth muscle cells from spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Cellular mechanisms of insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Angiotensin II inhibits insulin signaling in aortic smooth muscle cells at multiple levels. A potential role for serine phosphorylation in insulin/angiotensin II crosstalk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Effects of losartan in combination with or without exercise on insulin resistance in Otsuka Long-Evans Tokushima Fatty rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Src and Cas are essentially but differentially involved in angiotensin II-stimulated migration of vascular smooth muscle cells via extracellular signal-regulated kinase 1/2 and c-Jun NH2-terminal kinase activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Expression of a functional human insulin receptor from a cloned cDNA in Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

14-3-3 facilitates insulin-stimulated intracellular trafficking of insulin receptor substrate 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Effects of angiotensin II and insulin on ERK1/2 activation in fibroblasts from hypertensive patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Selective angiotensin II receptor antagonism reduces insulin resistance in obese Zucker rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

ACE inhibitor improves insulin resistance in diabetic mouse via bradykinin and NO.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Perspective: The insulin signaling system--a common link in the pathogenesis of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Insulin regulates protein kinase CbetaII alternative splicing in multiple target tissues: development of a hormonally responsive heterologous minigene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

High glucose concentrations and protein kinase C isoforms in vascular smooth muscle cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

IGF-I promotes a shift in metabolic flux in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2005.04.028

10.1016/J.YEXCR.2005.04.028

7 January 2021

Identifiers

DOI

1 reference

22 December 2017

release_mfknj4v4xrehha3kscqdhmf7gm

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mfknj4v4xrehha3kscqdhmf7gm

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

15921682

1 reference

22 December 2017